InvestorsHub Logo
Followers 5
Posts 475
Boards Moderated 0
Alias Born 09/27/2012

Re: Protector post# 101623

Tuesday, 11/13/2012 12:46:59 PM

Tuesday, November 13, 2012 12:46:59 PM

Post# of 346493
Nicely done. I would offer one more observation regarding the lawsuit. Referring to the complaint against CSM:

16. Additionally, CSM's breach(s) of contract may cause a delay in bringing Bavituximab to market and impact the value of the platform before commercialization, causing damages in an amount to be proven at trial.



We've heard nothing yet from management on the impact of the discrepancy, so it seems reasonable to assume that the impact of any delays to market can not be determined at this time. Accordingly, there would be little impetus to move the lawsuit forward until the actual damages can be evaluated. Just my layperson's observation, of course.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News